Methods for the Drug Effectiveness Review Project

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

2009 • 78,446 citations

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

2009 • 53,927 citations

Measuring inconsistency in meta-analyses

2003 • 53,662 citations

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

2009 • 44,660 citations

Quantifying heterogeneity in a meta‐analysis

2002 • 31,236 citations

The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis

2015 • 18,140 citations

Systematic reviews: CRD's guidance for undertaking reviews in health care

2010 • 2,620 citations

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1997 • 1,870 citations

Methods for Meta-Analysis in Medical Research

2000 • 1,803 citations

Current methods of the U.S. Preventive Services Task Force

2001 • 1,727 citations

Explaining heterogeneity in meta-analysis: a comparison of methods

1999 • 1,666 citations

Simultaneous comparison of multiple treatments: combining direct and indirect evidence

2005 • 1,457 citations

Evidence Synthesis for Decision Making 2

2012 • 1,017 citations

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

2003 • 935 citations

Finding What Works in Health Care: Standards for Systematic Reviews

2013 • 888 citations

Indirect comparisons of competing interventions

2005 • 674 citations

NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials

2011 • 494 citations

Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions

2007 • 194 citations

AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program

2008 • 175 citations

NICE DSU TECHNICAL SUPPORT DOCUMENT 3: HETEROGENEITY: SUBGROUPS, META-REGRESSION, BIAS AND BIAS-ADJUSTMENT

2011 • 144 citations

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

2006 • 107 citations

Indirect comparisons of treatments based on systematic reviews of randomised controlled trials

2009 • 75 citations

Direct versus indirect comparisons: A summary of the evidence

2008 • 64 citations

Observational studies in systemic reviews of comparative effectiveness: AHRQ and the Effective Health Care Program

2011 • 61 citations

In collaboration with the International Stroke Trial Collaborative Group. Indirect comparisons of competing interventions

2005 • 49 citations

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report

2010 • 34 citations

Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment

2012 • 32 citations

NICE DSU Technical Support Document 18

2011 • 23 citations

Decisions to update comparative drug effectiveness reviews vary based on type of new evidence

2011 • 16 citations

Drug Class Review: Proton Pump Inhibitors

2009 • 14 citations

Drug Class Review: Atypical Antipsychotic Drugs: Final Report Update 2

2008 • 4 citations

4. The Drug Effectiveness Review Project

2019 • 2 citations